Dennis M. Mulroy
2017
In 2017, Dennis M. Mulroy earned a total compensation of $2M as Chief Financial Officer at La Jolla Pharmaceutical, a 25% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Option Awards | $1,455,057 |
| Salary | $359,000 |
| Other | $19,979 |
| Total | $2,014,036 |
Mulroy received $1.5M in option awards, accounting for 72% of the total pay in 2017.
Mulroy also received $180K in non-equity incentive plan, $359K in salary and $20K in other compensation.
Rankings
In 2017, Dennis M. Mulroy's compensation ranked 5,475th out of 14,666 executives tracked by ExecPay. In other words, Mulroy earned more than 62.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,475 out of 14,666 | 63rd |
Division Manufacturing | 1,969 out of 5,770 | 66th |
Major group Chemicals And Allied Products | 593 out of 2,074 | 71st |
Industry group Drugs | 455 out of 1,730 | 74th |
Industry Biological Products, Except Diagnostic Substances | 84 out of 316 | 73rd |
Source: SEC filing on August 22, 2018.
Mulroy's colleagues
We found four more compensation records of executives who worked with Dennis M. Mulroy at La Jolla Pharmaceutical in 2017.